Tolinapant L-(+)-lactic acidProduct ingredient for Tolinapant

Show full entry for Tolinapant
Name
Tolinapant L-(+)-lactic acid
Drug Entry
Tolinapant

ASTX660 is under investigation in clinical trial NCT02503423 (Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas).

See full entry for Tolinapant
Accession Number
DBSALT003411
Structure
Synonyms
Not Available
UNII
Not Available
CAS Number
Not Available
Not Available
Predicted Properties
Not Available